VANCOUVER, BRITISH COLUMBIA–(Marketwired – June 6, 2016) – CRH Medical Corporation (TSX:CRH)(NYSE MKT:CRHM) (“CRH” or the “Company”), a North American medical company that provides physicians with innovative services and products for the treatment of gastrointestinal diseases, announces that it is scheduled to present at the upcoming Jefferies 2016 Healthcare Conference in New York.
Edward Wright, CEO of CRH Medical will be presenting on Thursday June 9, 2016 at 3:30 p.m. to investors attending the conference.
About CRH Medical Corporation:
CRH Medical Corporation is a North American company focused on providing physicians with innovative services and products for the treatment of gastrointestinal diseases. In 2014, CRH acquired a full service gastroenterology anesthesia company, Gastroenterology Anesthesia Associates, LLC (“GAA”), which provides anesthesia services for patients undergoing endoscopic procedures. CRH completed an acquisition of an anesthesia company in June 2016, and five acquisitions of anesthesia companies during the first, third and fourth quarters of 2015. Anesthesia assisted endoscopies make these procedures more comfortable for patients and allow gastroenterologists to perform more procedures. CRH plans to leverage the capabilities it acquired through GAA to continue to consolidate the highly fragmented gastroenterology anesthesia provider business. The Company’s product distribution strategy focuses on physician education, patient outcomes, and patient awareness. The Company’s first product, the CRH O’Regan System, is a single use, disposable, hemorrhoid banding technology that is safe and highly effective in treating hemorrhoid grades I – IV. CRH distributes the CRH O’Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to physicians, allowing CRH to create meaningful relationships with the physicians it serves. The Company’s goal is to establish CRH as the premier provider of essential services and innovative products to gastroenterologists throughout the United States.
David Matousek
Director of Investor Relations
800.660.2153 x1030
[email protected]
www.crhmedcorp.com
